Cubist Pharmaceuticals, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 1,054,442 926,359 753,972 636,458
Cost of Revenue 260,310 230,057 172,864 140,765
Gross Profit 794,132 696,302 581,108 495,693
Operating Expenses
Research and Development 477,740 277,729 184,533 157,854
Sales, General and Admin. 210,363 142,767 254,765 148,240
Non-Recurring Items 79,619 38,700 9,279 -
Other - - - -
Operating Income 26,410 237,106 132,531 189,599
Income From Continuing Operations
Add'l Income/Expense Items (32,452) (4,519) 3,673 (9,710)
Earnings Before Interest and Tax (6,042) 232,587 136,204 179,889
Interest Expense 37,602 32,991 31,415 25,580
Earnings Before Tax (43,644) 199,596 104,789 154,309
Income Tax (25,073) 45,521 71,766 59,984
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (18,571) 154,075 33,023 94,325
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (18,571) 154,075 33,023 94,325
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (18,571) 154,075 33,023 94,325